search
Back to results

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy (CILTUBE)

Primary Purpose

Salpingectomy, Hysterectomy, Primary Ciliary Dyskinesia

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
salpingectomy
hysterectomy
Sponsored by
Centre Hospitalier Intercommunal Creteil
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Salpingectomy focused on measuring miscarriage, tubal cilia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with scheduled salpingectomy (Ectopic pregnancy, hysterectomy for prolapsus, adenomyosis or myomectomy)
  • Major patients ( >18 years)

Exclusion Criteria:

  • Patient not willing to participate in the study

Sites / Locations

  • Centre Hospitalier Intercommunal CréteilRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Salpingectomy for Extra-Uterine Pregnancy

hysterectomies

Arm Description

patients with salpingectomy for Ectopic Pregnancy

patients with hysterectomy for prolapsus, adenomyosis or myomectomy

Outcomes

Primary Outcome Measures

morphological of tubal cilia
Molecular compositor of tubal ciliar by immunofluorescence study of 14 proteins in vivo and in vitro (tissue cells from patient fallopian tubes)
Molecular difference in tubal cilia between patients with or without GEU salpingectomy
compares molecular compositor of tubal ciliar by immunofluorecence study of 14 proteins in vivo and in vitro between patients with or without GEU salpingectomy
molecular tubal cilia
Ultrastructure morphology of tubal cell cilia by electron microscopy
functional composition of tubal cell by video microscopy
amplitude of moment by video microscopy
functional composition of tubal cell by video microscopy
frequency of moment by video microscopy

Secondary Outcome Measures

Full Information

First Posted
March 7, 2022
Last Updated
June 16, 2023
Sponsor
Centre Hospitalier Intercommunal Creteil
search

1. Study Identification

Unique Protocol Identification Number
NCT05374720
Brief Title
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
Acronym
CILTUBE
Official Title
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2022 (Actual)
Primary Completion Date
March 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Intercommunal Creteil

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women
Detailed Description
Primary Ciliary Dyskinesia (DCP) is a rare genetic disease (1 in 15,000 individuals at birth), which manifests itself in chronic respiratory infections (bronchopneumopathies and rhinosinusitis type) associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of sperm mobility. However, there is very little data in the literature on the structure and function of tubal cilia in women with DCP. Before considering a study of tubal cilia in patients with DCP, it seems necessary to specify in DCP patients or not DCP, the molecular and morphological composition of tubal cilia and to look for ciliary abnormalities in case of GEU

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Salpingectomy, Hysterectomy, Primary Ciliary Dyskinesia, Ectopic Pregnancy
Keywords
miscarriage, tubal cilia

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Salpingectomy for Extra-Uterine Pregnancy
Arm Type
Experimental
Arm Description
patients with salpingectomy for Ectopic Pregnancy
Arm Title
hysterectomies
Arm Type
Sham Comparator
Arm Description
patients with hysterectomy for prolapsus, adenomyosis or myomectomy
Intervention Type
Procedure
Intervention Name(s)
salpingectomy
Intervention Description
Removal of one of the fallopian tubes.
Intervention Type
Procedure
Intervention Name(s)
hysterectomy
Intervention Description
remove the uterus, whole or only part. It may also involve the removal of the cervix, ovaries, fallopian tubes and other surrounding structures.
Primary Outcome Measure Information:
Title
morphological of tubal cilia
Description
Molecular compositor of tubal ciliar by immunofluorescence study of 14 proteins in vivo and in vitro (tissue cells from patient fallopian tubes)
Time Frame
through study completion, an average of 6 week after surgery
Title
Molecular difference in tubal cilia between patients with or without GEU salpingectomy
Description
compares molecular compositor of tubal ciliar by immunofluorecence study of 14 proteins in vivo and in vitro between patients with or without GEU salpingectomy
Time Frame
through study completion, an average of 6 week after surgery
Title
molecular tubal cilia
Description
Ultrastructure morphology of tubal cell cilia by electron microscopy
Time Frame
through study completion, an average of 6 week after surgery
Title
functional composition of tubal cell by video microscopy
Description
amplitude of moment by video microscopy
Time Frame
through study completion, an average of 6 week after surgery
Title
functional composition of tubal cell by video microscopy
Description
frequency of moment by video microscopy
Time Frame
through study completion, an average of 6 week after surgery

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with scheduled salpingectomy (Ectopic pregnancy, hysterectomy for prolapsus, adenomyosis or myomectomy) Major patients ( >18 years) Exclusion Criteria: Patient not willing to participate in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rana MITRI- FRANGIEH
Phone
+33 01 57 02 22 86
Email
rana.mitri-frangieh@chicreteil.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Camille Jung
Email
camille.jung@chicreteil.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rana i MITRI-FRANGIEH
Organizational Affiliation
Centre Hospitalier Intercommunal Créteil
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Intercommunal Créteil
City
Créteil
State/Province
Val-deMarne
ZIP/Postal Code
94000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rana i MITRI-FRANGIEH
Phone
+33157022286
Email
rana.mitri-frangieh@chicreteil.fr

12. IPD Sharing Statement

Learn more about this trial

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

We'll reach out to this number within 24 hrs